-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on LeonaBio, Lowers Price Target to $16

Benzinga·11/17/2026 14:12:42
Listen to the news
Citizens analyst Jason N. Butler maintains LeonaBio (NASDAQ:LONA) with a Market Outperform and lowers the price target from $17 to $16.